-
1
-
-
33947724515
-
HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells
-
Fukuda R, Zhang H, Kim JW, et al: HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129: 111-122, 2007.
-
(2007)
Cell
, vol.129
, pp. 111-122
-
-
Fukuda, R.1
Zhang, H.2
Kim, J.W.3
-
2
-
-
33745138232
-
Regulation of angiogenesis by hypoxia-inducible factor 1
-
Hirota K and Semenza GL: Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol 59: 15-26, 2006.
-
(2006)
Crit Rev Oncol Hematol
, vol.59
, pp. 15-26
-
-
Hirota, K.1
Semenza, G.L.2
-
3
-
-
34047105144
-
Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance
-
Kilic M, Kasperczyk H, Fulda S and Debatin KM: Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance. Oncogene 26: 2027-2038, 2007.
-
(2007)
Oncogene
, vol.26
, pp. 2027-2038
-
-
Kilic, M.1
Kasperczyk, H.2
Fulda, S.3
Debatin, K.M.4
-
4
-
-
33645748171
-
Regulation of E-cadherin expression by VHL and hypoxia-inducible factor
-
Esteban MA, Tran MG, Harten SK, et al: Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Res 66: 3567-3575, 2006.
-
(2006)
Cancer Res
, vol.66
, pp. 3567-3575
-
-
Esteban, M.A.1
Tran, M.G.2
Harten, S.K.3
-
5
-
-
33644911773
-
Knockdown of hypoxia-inducible factor-1alpha in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate
-
Li J, Shi M, Cao Y, et al: Knockdown of hypoxia-inducible factor-1alpha in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate. Biochem Biophys Res Commun 342: 1341-1351, 2006.
-
(2006)
Biochem Biophys Res Commun
, vol.342
, pp. 1341-1351
-
-
Li, J.1
Shi, M.2
Cao, Y.3
-
6
-
-
0032493368
-
Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway
-
Huang LE, Gu J, Schau M and Bunn HF: Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95: 7987-7992, 1998.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 7987-7992
-
-
Huang, L.E.1
Gu, J.2
Schau, M.3
Bunn, H.F.4
-
7
-
-
0037070223
-
Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway
-
Stiehl DP, Jelkmann W, Wenger RH and Hellwig-Bürgel T: Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway. FEBS Lett 512: 157-162, 2002.
-
(2002)
FEBS Lett
, vol.512
, pp. 157-162
-
-
Stiehl, D.P.1
Jelkmann, W.2
Wenger, R.H.3
Hellwig-Bürgel, T.4
-
8
-
-
0036710591
-
Signal transduction to hypoxia-inducible factor 1
-
Semenza G: Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64: 993-998, 2002.
-
(2002)
Biochem Pharmacol
, vol.64
, pp. 993-998
-
-
Semenza, G.1
-
9
-
-
22144493866
-
Negative and positive regulation of HIF-1: A complex network
-
Bárdos JI and Ashcrof M: Negative and positive regulation of HIF-1: a complex network. Biochim Biophys Acta 1755: 107-120, 2005.
-
(2005)
Biochim Biophys Acta
, vol.1755
, pp. 107-120
-
-
Bárdos, J.I.1
Ashcrof, M.2
-
10
-
-
0033571682
-
Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases
-
Zhong H, De Marzo AM, Laughner E, et al: Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59: 5830-5835, 1999.
-
(1999)
Cancer Res
, vol.59
, pp. 5830-5835
-
-
Zhong, H.1
De Marzo, A.M.2
Laughner, E.3
-
12
-
-
0142166332
-
Targeting HIF-1 for cancer therapy
-
Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732, 2003.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 721-732
-
-
Semenza, G.L.1
-
13
-
-
84859445000
-
Hypoxia-inducible factors: Mediators of cancer progression and targets for cancer therapy
-
Semenza GL: Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 33: 207-214, 2012.
-
(2012)
Trends Pharmacol Sci
, vol.33
, pp. 207-214
-
-
Semenza, G.L.1
-
14
-
-
0344608877
-
Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism
-
Chen J, Zhao S, Nakada K, et al: Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol 162: 1283-1291, 2003.
-
(2003)
Am J Pathol
, vol.162
, pp. 1283-1291
-
-
Chen, J.1
Zhao, S.2
Nakada, K.3
-
15
-
-
84872065517
-
Autocrine functions of VEGF in breast tumor cells: Adhesion, survival, migration and invasion
-
Perrot-Applanat M and Di Benedetto M: Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion. Cell Adh Migr 6: 547-553, 2012.
-
(2012)
Cell Adh Migr
, vol.6
, pp. 547-553
-
-
Perrot-Applanat, M.1
Di Benedetto, M.2
-
16
-
-
84866748197
-
The effect of erythropoietin on normal and neoplastic cells
-
Elliott S and Sinclair AM: The effect of erythropoietin on normal and neoplastic cells. Biologics 6: 163-189, 2012.
-
(2012)
Biologics
, vol.6
, pp. 163-189
-
-
Elliott, S.1
Sinclair, A.M.2
-
17
-
-
34548710861
-
Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway
-
Zheng H, Fu G, Dai T and Huang H: Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 50: 274-280, 2007.
-
(2007)
J Cardiovasc Pharmacol
, vol.50
, pp. 274-280
-
-
Zheng, H.1
Fu, G.2
Dai, T.3
Huang, H.4
-
18
-
-
84878198393
-
Perspectives on treatment of metastatic castration-resistant prostate cancer
-
Merseburger AS, Bellmunt J, Jenkins C, et al: Perspectives on treatment of metastatic castration-resistant prostate cancer. Oncologist 18: 558-567, 2013.
-
(2013)
Oncologist
, vol.18
, pp. 558-567
-
-
Merseburger, A.S.1
Bellmunt, J.2
Jenkins, C.3
-
19
-
-
35349001759
-
Inhibition of VEGF expression by targeting HIF-1alpha with small interference RNA in human RPE cells
-
Zhang P, Wang Y, Hui Y, et al: Inhibition of VEGF expression by targeting HIF-1alpha with small interference RNA in human RPE cells. Ophthalmologica 221: 411-417, 2007.
-
(2007)
Ophthalmologica
, vol.221
, pp. 411-417
-
-
Zhang, P.1
Wang, Y.2
Hui, Y.3
-
20
-
-
33749362031
-
Inhibiting hypoxia-inducible factor 1 for cancer therapy
-
Melillo G: Inhibiting hypoxia-inducible factor 1 for cancer therapy. Mol Cancer Res 4: 601-605, 2006.
-
(2006)
Mol Cancer Res
, vol.4
, pp. 601-605
-
-
Melillo, G.1
-
21
-
-
33745767945
-
Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas
-
Jensen RL, Ragel BT, Whang K and Gillespie D: Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. J Neurooncol 78: 233-247, 2006.
-
(2006)
J Neurooncol
, vol.78
, pp. 233-247
-
-
Jensen, R.L.1
Ragel, B.T.2
Whang, K.3
Gillespie, D.4
-
22
-
-
2942685341
-
Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation
-
Stoeltzing O, McCarty MF, Wey JS, et al: Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst 96: 946-956, 2004.
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 946-956
-
-
Stoeltzing, O.1
McCarty, M.F.2
Wey, J.S.3
-
23
-
-
31044444974
-
Reversing hypoxic cell chemoresistance in vitro using genetic and small molecule approaches targeting hypoxia inducible factor-1
-
Brown LM, Cowen RL, Debray C, et al: Reversing hypoxic cell chemoresistance in vitro using genetic and small molecule approaches targeting hypoxia inducible factor-1. Mol Pharmacol 69: 411-418, 2006.
-
(2006)
Mol Pharmacol
, vol.69
, pp. 411-418
-
-
Brown, L.M.1
Cowen, R.L.2
Debray, C.3
|